December 2015

Three Proposals to Reform the 340B Drug Discount Program

December 10, 2015

Evidence-Based Oncology

The 340B Drug Discount Program has rapidly expanded over the last few years and may be missing its original intent. Here are 3 possible steps that could enhance the program’s function and mirror Congress’ original intent to enhance access for the poor to essential medical services.

Is There a Mathematical Resolution to the Cost-Versus-Value Debate?

December 11, 2015

Evidence-Based Oncology

Solutions proposed by patient advocates and physicians to control costs provide approaches to valuing new drug/treatments compared with 1 or several prevailing standards of care. Increasingly, however, the debate over cost is transitioning to a debate over value.

Managing Costs and Enhancing the Value of Oncology Care

December 11, 2015

Evidence-Based Oncology

Management of high and rising costs in oncology requires a multifaceted approach using both innovative strategies and pragmatic tools. In this article, we discuss several factors that influence the costs of oncology care.

Eliminating a Barrier to Cancer Care through Universal Fair Access to Oral Chemotherapy Medications

December 14, 2015

Evidence-Based Oncology

The advocacy affiliate of the American Cancer Society, the American Cancer Society Cancer Action Network, is working across the country to pass and implement strong oral chemotherapy fairness laws to help ensure cancer patients have access to the recommended course of treatment without added out-of-pocket costs based on how their drug is administered.

The Financial Impact of Cancer Care: Implications and Potential Solutions

December 14, 2015

Evidence-Based Oncology

Addressing the financial burden of cancer treatment requires efforts at the policy, payer, and clinic level, and implementation of these strategies, in clinical practice, requires commitment from various stakeholders.

Patient Access to Oncology Care in ACA Exchange Plans

December 15, 2015

Evidence-Based Oncology

This article describes provider networks and benefit design-including deductibles, cost-sharing, and maximum out-of-pocket limits-for oncology care in 2015 health insurance exchanges.

The Struggle Between Oncology Care Cost and Value

December 15, 2015

Evidence-Based Oncology

While cost is an important component of value, it tells only a small part of the cancer care story. By focusing on issues of payment and cost alone, we miss our opportunity to engage cancer care stakeholders in the process of creating a more effective system of care.

ACCC ICLIO meeting

December 15, 2015

Evidence-Based Oncology

At the first annual conference of the Institute for Clinical Immuno-Oncology on October 1, 2015, in Philadelphia, the discussion revolved around integrating immuno-oncology into clinical practice and programs that assist with patient access to these treatments.

Managed Care Updates: Oncology

December 16, 2015

Evidence-Based Oncology

Updates on screening age recommendations for mammograms, CDC report on a decline in smoking rates in the country, and regulation of laboratory-developed tests.